Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thrombolytic therapy for acute stroke--not a moment to lose.

Literature DB >> 18815401

Thrombolytic therapy for acute stroke--not a moment to lose.

Patrick Lyden.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2008 PMID： 18815401 DOI： 10.1056/NEJMe0806335

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

20 in total

1. Interhospital Facility Transfers in the United States: A Nationwide Outcomes Study.

Authors: Tina Hernandez-Boussard; Sheryl Davies; Kathryn McDonald; N Ewen Wang
Journal: J Patient Saf Date: 2017-12 Impact factor: 2.844

2. Stroke: Haemorrhage risk after thrombolysis--the SEDAN score.

Authors: Patrick D Lyden
Journal: Nat Rev Neurol Date: 2012-04-17 Impact factor: 42.937

Review 3. 14-3-3gamma and neuroglobin are new intrinsic protective factors for cerebral ischemia.

Authors: Yan Dong; Rui Zhao; Xiao Qian Chen; Albert Cheung Hoi Yu
Journal: Mol Neurobiol Date: 2010-05-14 Impact factor: 5.590

4. Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program.

Authors: Natalia S Rost; Eric E Smith; Muhammad A Pervez; Philip Mello; Paul Dreyer; Lee H Schwamm
Journal: Circ Cardiovasc Qual Outcomes Date: 2012-04-24

5. Analysis of the National Institute of Neurological Disorders and Stroke tissue plasminogen activator studies following European Cooperative Acute Stroke Study III patient selection criteria.

Authors: Thomas M Hemmen; Karen S Rapp; Jennifer A Emond; Rema Raman; Patrick D Lyden
Journal: J Stroke Cerebrovasc Dis Date: 2010-05-14 Impact factor: 2.136

6. Administration of tissue plasminogen activator without coagulation results in a Chinese population.

Authors: Xiaoming Qin; Songyao Zhao; Liujie Yin; Hailing Dou; Jie Chen; Yifan Wang; Mingzhe Li; Ruifang Chen; Jing Fu; Wei Liu; Xin Liu; Gaiqing Yang; Runqing Wang; Xinzhou Jia; Shufang Bu; Dongpu Ma; Baoyu Wang; Shize Li
Journal: Neurol Sci Date: 2018-01-03 Impact factor: 3.307

Thrombolytic therapy for acute stroke--not a moment to lose.

1. Interhospital Facility Transfers in the United States: A Nationwide Outcomes Study.

2. Stroke: Haemorrhage risk after thrombolysis--the SEDAN score.

Review 3. 14-3-3gamma and neuroglobin are new intrinsic protective factors for cerebral ischemia.

4. Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program.

5. Analysis of the National Institute of Neurological Disorders and Stroke tissue plasminogen activator studies following European Cooperative Acute Stroke Study III patient selection criteria.

6. Administration of tissue plasminogen activator without coagulation results in a Chinese population.

7. Thrombolytic Therapy for Acute Ischemic Stroke.

Review 8. Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence.

9. Emergency neurological care of strokes and bleeds.

10. Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke.